FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1587762479> ?p ?o ?g. }

• W1587762479 endingPage "1897" @default.
• W1587762479 startingPage "1890" @default.
• W1587762479 abstract "BACKGROUND Chemotherapy-induced peripheral neuropathy (CIPN) is a significant side effect of taxane and platinum-based chemotherapy. Several studies have supported the potential benefit of glutathione for the prevention of platinum-induced CIPN. The current trial was designed to determine whether glutathione would prevent CIPN as a result of carboplatin/paclitaxel therapy. METHODS In total, 185 patients who received treatment with paclitaxel and carboplatin were accrued between December 4, 2009 and December 19, 2011. Patients were randomized to receive either placebo (n = 91) or 1.5 g/m2 glutathione (n = 94) over 15 minutes immediately before chemotherapy. CIPN was assessed using the European Organization for Research and Treatment of Cancer Quality-of-Life (EORTC-QLQ) 20-item, CIPN-specific (CIPN20) sensory subscale and the National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), version 4.0. RESULTS There were no statistically significant differences between the 2 study arms with regard to: 1) peripheral neurotoxicity, as assessed using both the EORTC-QLQ-CIPN20 (P = .21) and the CTCAE scales (P = .449 for grade ≥2 neurotoxicity; P = .039 for time to development of grade ≥2 neuropathy, in favor of the placebo); 2) the degree of paclitaxel acute pain syndrome (P = .30 for patients who received paclitaxel every 3-4 weeks and P = .002, in favor of the placebo, for patients who received weekly paclitaxel); 3) the time to disease progression (P = .63); or 4) apparent toxicities. Subgroup analyses did not reveal any evidence of benefit in any particular subgroup. CONCLUSIONS The results from this study do not support the use of glutathione for the prevention of paclitaxel/carboplatin-induced CIPN. Cancer 2014;120:1890–1897. © 2014 American Cancer Society." @default.
• W1587762479 created "2016-06-24" @default.
• W1587762479 creator A5002652857 @default.
• W1587762479 creator A5008767553 @default.
• W1587762479 creator A5027306320 @default.
• W1587762479 creator A5027785733 @default.
• W1587762479 creator A5044333558 @default.
• W1587762479 creator A5049098778 @default.
• W1587762479 creator A5068938207 @default.
• W1587762479 creator A5084759728 @default.
• W1587762479 creator A5085210286 @default.
• W1587762479 creator A5089153267 @default.
• W1587762479 creator A5089940443 @default.
• W1587762479 date "2014-03-11" @default.
• W1587762479 modified "2023-10-12" @default.
• W1587762479 title "North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study" @default.
• W1587762479 cites W1522874901 @default.
• W1587762479 cites W1832113570 @default.
• W1587762479 cites W1971032720 @default.
• W1587762479 cites W1981575902 @default.
• W1587762479 cites W1992820423 @default.
• W1587762479 cites W1994422014 @default.
• W1587762479 cites W2000366267 @default.
• W1587762479 cites W2006613730 @default.
• W1587762479 cites W2010230774 @default.
• W1587762479 cites W2012350074 @default.
• W1587762479 cites W2012662529 @default.
• W1587762479 cites W2016448869 @default.
• W1587762479 cites W2028018692 @default.
• W1587762479 cites W2032268538 @default.
• W1587762479 cites W2035062443 @default.
• W1587762479 cites W2035314266 @default.
• W1587762479 cites W2035370590 @default.
• W1587762479 cites W2035598226 @default.
• W1587762479 cites W2042419207 @default.
• W1587762479 cites W2046026783 @default.
• W1587762479 cites W2049593742 @default.
• W1587762479 cites W2057662279 @default.
• W1587762479 cites W2059588106 @default.
• W1587762479 cites W2062644255 @default.
• W1587762479 cites W2063885093 @default.
• W1587762479 cites W2067188860 @default.
• W1587762479 cites W2070825651 @default.
• W1587762479 cites W2072868648 @default.
• W1587762479 cites W2076026772 @default.
• W1587762479 cites W2087401864 @default.
• W1587762479 cites W2087440975 @default.
• W1587762479 cites W2094267095 @default.
• W1587762479 cites W2127933589 @default.
• W1587762479 cites W2131470221 @default.
• W1587762479 cites W2131762605 @default.
• W1587762479 cites W2136686417 @default.
• W1587762479 cites W2140464421 @default.
• W1587762479 cites W2142769493 @default.
• W1587762479 cites W2148454282 @default.
• W1587762479 cites W2150112288 @default.
• W1587762479 cites W2156533107 @default.
• W1587762479 cites W2161209374 @default.
• W1587762479 cites W2162730620 @default.
• W1587762479 cites W2163503241 @default.
• W1587762479 cites W2244770355 @default.
• W1587762479 cites W2336407319 @default.
• W1587762479 cites W2613229880 @default.
• W1587762479 cites W4242872483 @default.
• W1587762479 cites W4293241248 @default.
• W1587762479 doi "https://doi.org/10.1002/cncr.28654" @default.
• W1587762479 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4047184" @default.
• W1587762479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24619793" @default.
• W1587762479 hasPublicationYear "2014" @default.
• W1587762479 type Work @default.
• W1587762479 sameAs 1587762479 @default.
• W1587762479 citedByCount "71" @default.
• W1587762479 countsByYear W15877624792014 @default.
• W1587762479 countsByYear W15877624792015 @default.
• W1587762479 countsByYear W15877624792016 @default.
• W1587762479 countsByYear W15877624792017 @default.
• W1587762479 countsByYear W15877624792018 @default.
• W1587762479 countsByYear W15877624792019 @default.
• W1587762479 countsByYear W15877624792020 @default.
• W1587762479 countsByYear W15877624792021 @default.
• W1587762479 countsByYear W15877624792022 @default.
• W1587762479 countsByYear W15877624792023 @default.
• W1587762479 crossrefType "journal-article" @default.
• W1587762479 hasAuthorship W1587762479A5002652857 @default.
• W1587762479 hasAuthorship W1587762479A5008767553 @default.
• W1587762479 hasAuthorship W1587762479A5027306320 @default.
• W1587762479 hasAuthorship W1587762479A5027785733 @default.
• W1587762479 hasAuthorship W1587762479A5044333558 @default.
• W1587762479 hasAuthorship W1587762479A5049098778 @default.
• W1587762479 hasAuthorship W1587762479A5068938207 @default.
• W1587762479 hasAuthorship W1587762479A5084759728 @default.
• W1587762479 hasAuthorship W1587762479A5085210286 @default.
• W1587762479 hasAuthorship W1587762479A5089153267 @default.
• W1587762479 hasAuthorship W1587762479A5089940443 @default.
• W1587762479 hasBestOaLocation W15877624791 @default.
• W1587762479 hasConcept C121608353 @default.
• W1587762479 hasConcept C126322002 @default.
• W1587762479 hasConcept C134018914 @default.

• next